메뉴 건너뛰기




Volumn 11, Issue 4, 2000, Pages 13-16

Modified-release preparations
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADIPINE MR; ADIZEM SR; ADIZEM XL; AMINOPHYLLINE; ANGIOPIN MR; ANGIOZEM CR; ANGITIL SR; ANGITIL XL; BI CARZEM SR; CALCICARD CR; CARBAMAZEPINE; DILCARDIA SR; DILTIAZEM; DILZEM SR; DILZEM XL; IBUPROFEN; LITHIUM; MESALAZINE; MORPHINE SULFATE; NIFEDIPINE; NU SEALS ASPIRIN; OPTIL SR; OPTIL XL; PHYLLOCONTIN CONTINUS; PROPRANOLOL; SALBUTAMOL SULFATE; SLOZEM XL; THEOPHYLLINE; TILDIEM LA; VIAZEM XL; ZEMTARD XL;

EID: 0033825019     PISSN: 14655659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (6)

References (20)
  • 1
    • 0008078263 scopus 로고    scopus 로고
    • Quality and performance in the NHS: NHS performance indicators. NHS Executive
    • (2000)
  • 2
    • 0008151842 scopus 로고    scopus 로고
    • British Pharmacopoeia. London: HMSO
    • (1999)
  • 3
    • 0008076895 scopus 로고
    • British Pharmaceutical Codex. Principles and Practice of Pharmaceutics, 12th Edition. London: The Pharmaceutical Press
    • (1994)
  • 4
    • 0031689801 scopus 로고    scopus 로고
    • Once a day is best: Evidence or assumption? The relationship between compliance and dosage frequency in older people
    • (1998) Drugs Aging , vol.13 , pp. 223-227
    • Pushpangadan, M.1    Feely, M.2
  • 6
    • 0021241325 scopus 로고
    • Overview of patient compliance with medication dosing: A literature review
    • (1984) Clin Ther , vol.6 , pp. 592-599
    • Greenberg, R.N.1
  • 8
  • 10
    • 0027975411 scopus 로고
    • Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: A comparative study
    • (1994) J Int Med Res , vol.22 , pp. 266-272
    • Brun, J.1
  • 14
    • 0008073690 scopus 로고    scopus 로고
    • Modified-release drugs for cardiovascular disorders
    • (1997) Prescriber , vol.8 , Issue.7 , pp. 19-31
    • Waller, D.1
  • 15
    • 0008027099 scopus 로고    scopus 로고
    • Modified-release drugs why, when and how?
    • (1996) Prescriber , vol.7 , Issue.22 , pp. 77-81
    • Chaplin, S.1
  • 16
    • 0008078266 scopus 로고    scopus 로고
    • British National Formulary. London. March
    • (2000) , vol.39
  • 17
    • 0034729993 scopus 로고    scopus 로고
    • Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
    • (2000) Lancet , vol.356 , pp. 366-372
    • Brown, M.J.1    Palmer, C.R.2
  • 18
    • 0008151844 scopus 로고    scopus 로고
    • Sowerby Centre for Health Informatics at Newcastle. PRODIGY Hypertension Guidance Jan 2000 and PRODIGY Angina Guidance July 1999
  • 19
    • 85007669728 scopus 로고    scopus 로고
    • Drug treatment of epilepsy
    • (1999) BMJ , vol.318 , pp. 106-109
    • Feely, M.1
  • 20
    • 0000025887 scopus 로고
    • Royal Pharmaceutical Society Council Advice. Solid oral modified-release preparations
    • (1993) Pharm J , vol.251 , pp. 528


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.